Reich DS, Arnold DL, Vermersch P, Bar-Or A, et al. Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in
relapsing multiple sclerosis: a phase 2b, randomised, double-blind,
placebo-controlled trial. Lancet Neurol 2021;20:729-738.
PMID: 34418400